Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1a expression

Cellular Oncology

Volumn 34, Issue 6, 2011, Pages 565-570

  Hyseni, Agon ^a   Van Der Groep, Petra ^a   Van Der Wall, Elsken ^a   Van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Breast cancer; Hypoxia; Immunohistochemistry; Prognosis

Indexed keywords

CARBONATE DEHYDRATASE IX; FACTOR INHIBITING HYPOXIA INDUCIBLE FACTOR 1; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; HIF1AN PROTEIN, HUMAN; MIXED FUNCTION OXIDASE; REPRESSOR PROTEIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CYTOPLASM; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; FEMALE; IN VITRO STUDY; METABOLISM;

BREAST NEOPLASMS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MIXED FUNCTION OXYGENASES; REPRESSOR PROTEINS;

EID: 84861494579     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0053-5     Document Type: Article

References (40)

1. P. Vaupel, K. Schlenger, C. Knoop, M. Höckel, Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Canc. Res. 51 (12), 3316-3322 (1991)
2. A.L. Harris, Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Canc. 2(1), 38-47 (2002) (Pubitemid 37328806)
3. G.L. Semenza, Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551-578 (1999) (Pubitemid 32250386)
4. A. Greijer, P. van der Groep, D. Kemming, A. Shvarts, G. Semenza, G. Meijer, M. van de Wiel, J. Belien, P. van Diest, E. van der Wall, Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J. Pathol. 206, 291-304 (2005) (Pubitemid 40903193)
5. G.L. Wang, B.H. Jiang, E.A. Rue, G.L. Semenza, Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92 (12), 5510-5514 (1995)
6. L. Seeber, N. Horree, P. van der Groep et al., Perinecrotic HIF-1 alpha expression and necrosis predict prognosis in patients with endometrioid endometrial carcinoma. Cell. Oncol. 30, 158 (2008)
7. T. Fillies, R. Werkmeister, P.J. van Diest, B. Brandt, U. Joos, H. Buerger, HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Canc. 5, 84 (2005)
8. R. Bos, H. Zhong, C.F. Hanrahan, E.C.M. Mommers, G.L. Semenza, H.M. Pinedo, M.D. Abeloff, J.W. Simons, P.J. van Diest, E. van der Wall, Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Canc. Inst. 93(4), 309-14 (2001) (Pubitemid 32219818)
9. P. Van Der Groep, A. Bouter, F.H. Menko, E. van der Wall, P.J. van Diest, High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. Breast Canc. Res. Treat. 111(3), 475-480 (2008)
10. U. Woelfle, J. Cloos, G. Sauter, L. Riethdorf, F. Jänicke, P. Van Diest, R. Brakenhoff, K. Pantel, Molecular signature associated with bone marrow micrometastasis in human breast cancer. Canc. Res. 63, 5679-5684 (2003) (Pubitemid 37187461)
11. R. Bos, P.J. Van Diest, J.S. De Jong, P. Van der Groep, P. Van der Valk, E. Van der Wall, Hypoxia-inducible factor-1a is associated with angiogenesis and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46, 31-36 (2005) (Pubitemid 40193695)
12. R. Bos, P. Van Der Groep, A.E. Greijer, A. Shvarts, S. Meijer, H. M. Pinedo, G.L. Semenza, P.J. Van Diest, E. Van Der Wall, Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97, 1573-1581 (2003) (Pubitemid 36297788)
13. J.P. Dales, S. Garcia, S. Meunier-Carpentier, L. Andrac-Meyer, O. Haddad, M.N. Lavaut, C. Allasia, P. Bonnier, C. Charpin, Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int. J. Canc. 116(5), 734-739 (2005) (Pubitemid 41099705)
14. E.Y. Tan, M. Yan, L. Campo, C. Han, E. Takano, H. Turley, I. Candiloro, F. Pezzella, K.C. Gatter, E.K. Millar, S.A. O'Toole, C. M. McNeil, P. Crea, D. Segara, R.L. Sutherland, A.L. Harris, S.B. Fox, The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br. J. Canc. 100(2), 405-411 (2009)
15. A.E. Greijer, M.C. De Jong, G.L. Scheffer, A. Shvarts, P.J. Van Diest, E. Van der Wall, Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells. Cell. Oncol. 27, 43-49 (2005) (Pubitemid 40387191)
16. R. Bos, J.J.M. van der Hoeven, E. van der Wall, P. van der Groep, P.J. van Diest, E.F.I. Comans, U. Joshi, G.L. Semenza, O.S. Hoekstra, A.A. Lammertsma, C.F.M. Molthoff, Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J. Clin. Oncol. 20, 379-387 (2002) (Pubitemid 34072519)
17. N. Horree, P.J. van Diest, P. van der Groep, D.M. Sie-Go, A.P. Heintz, Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis. Cell. Oncol. 29, 219-227 (2007) (Pubitemid 46855701)
18. N. Horree, E. Gort, P. van der Groep, A. Heintz, M. Vooijs, P. van Diest, Hypoxia-inducible factor 1alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma. J. Pathol. 214, 38-45 (2008)
19. M.M. Vleugel, A.E. Greijer, A. Shvarts, P. van der Groep, M. van Berkel, Y. Aarbodem, H. van Tinteren, A.L. Harris, P.J. van Diest, E. van der Wall, Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J. Clin. Pathol. 58(2), 172-177 (2005) (Pubitemid 40193803)
20. O.R. Saramäki, K.J. Savinainen, N.N. Nupponen, O. Bratt, T. Visakorpi, Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer. Canc. Genet. Cytogenet. 128(1), 31-34 (2001) (Pubitemid 32655478)
21. M.M. Vleugel, R. Bos, H. Buerger, P. Van der Groep, O.R. Saramäki, T. Visakorpi, E. Van der Wall, P.J. Van Diest, No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study. Cell. Oncol. 26, 347-351 (2004) (Pubitemid 40916735)
22. M.M. Vleugel, A.E. Greijer, E. Van der Wall, P.J. Van Diest, Mutation analysis of the HIF-1a oxygen-dependent degradation domain in invasive breast cancer. Canc. Genet. Cytogenet. 163, 168-172 (2005) (Pubitemid 41758460)
23. M.M. Vleugel, D. Shvarts, E. van der Wall, P.J. van Diest, p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer. Hum. Pathol. 37, 1085-1092 (2006) (Pubitemid 44080822)
24. K. Lisy, D.J. Peet, Turn me on: regulating HIF transcriptional activity. Cell Death Differ. 15(4), 642-649 (2008) (Pubitemid 351405067)
25. F. Dayan, D. Roux, M.C. Brahimi-Horn, J. Pouyssegur, N.M. Mazure, The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Canc. Res. 66(7), 3688-3698 (2006)
26. S.G. Kroeze, J.S. Vermaat, A. van Brussel, H.H. van Melick, E.E. Voest, T.G. Jonges, P.J. van Diest, J. Hinrichs, J.L. Bosch, J.J. Jans, Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients. Eur. J. Canc. 46(18), 3375-82 (2010)
27. E.Y. Tan, L. Campo, C. Han, H. Turley, F. Pezzella, K.C. Gatter, A. L. Harris, S.B. Fox, Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Breast Canc. Res. 9(6), R89 (2007)
28. P.J. Van Diest, J.P.A. Baak, P. Matze-Cok, E.C.M. Wisse-Brekelmans, C.M. van Galen, P.H.J. Kurver, S.M. Bellot, J. Fijnheer, L.H.M. van Gorp, W.S. Kwee, J. Los, J.L. Peterse, H.M. Ruitenberg, R.F.M. Schapers, M.E.I. Schipper, J.G. Somsen, A.W. P.M. Willig, A.Th. Ariens, Reproducibility of mitosis counting in 2469 breast cancer specimens: Results from the Multicenter Morphometric Mammary Carcinoma Project. Hum. Pathol. 23, 603-607 (1992)
29. C.W. Elston, I.O. Ellis, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19, 403-410 (1991)
30. P.J. Van Diest, No consent should be needed for using leftover body material for scientific purposes. BMJ 325, 648-651 (2002)
31. E.H. Gort, A.J. Groot, E. van derWall, P.J. van Diest, M.A. Vooijs, Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr. Mol. Med. 8(1), 60-67 (2008) (Pubitemid 351516825)
32. E. Metzen, U. Berchner-Pfannschmidt, P. Stengel, J.H. Marxsen, I. Stolze, M. Klinger, W.Q. Huang, C. Wotzlaw, T. Hellwig-Bürgel, W. Jelkmann, H. Acker, J. Fandrey, Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J. Cell Sci. 116(Pt 7), 1319-1326 (2003) (Pubitemid 36410669)
33. E.J. Soilleux, H. Turley, Y.M. Tian, C.W. Pugh, K.C. Gatter, A.L. Harris, Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues. Histopathology 47(6), 602-610 (2005) (Pubitemid 41775183)
34. A. Couvelard, L. Deschamps, V. Rebours, A. Sauvanet, K. Gatter, F. Pezzella, P. Ruszniewski, P. Bedossa, Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. Clin. Canc. Res. 14(20), 6634-6639 (2008)
35. H. Fukuba, T. Takahashi, H.G. Jin, T. Kohriyama, M. Matsumoto, Abundance of aspargynyl-hydroxylase FIH is regulated by Siah-1 under normoxic conditions. Neurosci. Lett. 433(3), 209-214 (2008)
36. H. Fukuba,H.Yamashita,Y.Nagano,H.G. Jin, M. Hiji, T.Ohtsuki, T. Takahashi, T. Kohriyama, M. Matsumoto, Siah-1 facilitates ubiquitination and degradation of factor inhibiting HIF-1alpha (FIH). Biochem. Biophys. Res. Commun. 353(2), 324-329 (2007) (Pubitemid 46014568)
37. X. Zheng, S. Linke, J.M. Dias, X. Zheng, K. Gradin, T.P. Wallis, B.R. Hamilton, M. Gustafsson, J.L. Ruas, S. Wilkins, R.L. Bilton, K. Brismar, M.L. Whitelaw, T. Pereira, J.J. Gorman, J. Ericson, D. J. Peet, U. Lendahl, L. Poellinger, Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc. Natl. Acad. Sci. USA 105(9), 3368-3373 (2008) (Pubitemid 351723559)
38. D. Barrick, R. Kopan, The Notch transcription activation complex makes its move. Cell 124(5), 883-885 (2006) (Pubitemid 43344226)
39. S. Bray, A Notch affair. Cell 93(4), 499-503 (1998) (Pubitemid 28240712)
40. J.S. Mumm, R. Kopan, Notch signaling: from the outside in. Dev. Biol. 228(2), 151-165 (2000) (Pubitemid 32011983)